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Abstract
Introduction: Dermatomyositis is an important inflammation of skin and muscles. Generalised itch
is frequent in the condition; however, symptomatic dermographism has not previously been reported
as a presenting feature.
Case presentation: A 32-year-old Caucasian Scottish woman was diagnosed with dermatomyositis
after initial presentation with symptomatic dermographism. No underlying neoplasm was found and
her condition was successfully treated with systemic corticosteroids and high-dose human
immunoglobulin infusions. At presentation, her troponin T and creatine phosphokinase enzymes
were highly raised.
Conclusion: Symptomatic dermographism may be a presenting feature of dermatomyositis.
Dermatomyositis is one of many conditions that can result in a raised troponin T.
Introduction
When it presents in its classical form, dermatomyositis is
easy to diagnose, with typical redness and scaling over-
lying the knuckles, purple-red discolouration especially
about the upper eyelids and often associated with some
eyelid oedema, redness over the upper back and shoulders
(the “shawl sign”) along with a predominantly proximal
upper and lower limb muscle weakness. However, when it
presents without this complete picture, diagnosis can be
far harder. It is an important condition to diagnose,
because it can in itself be a life changing and sometimes
life threatening condition, and because when occurring
with onset in adulthood it is important to look for a
possible underlying neoplasm. Generalised itch is well
recognised in the dermatological literature [1,2] as an
important feature of dermatomyositis, although less
attention is given to itch as a symptom in standard general
medical textbooks [3]. However, dermographism (linear
urticaria in response to stroking the skin) has not been
previously described as a feature of this disease.
Case presentation
A 32-year-old Caucasian Scottish woman was attending
thrice weekly for a second course of narrowband ultravio-
let B (UVB) phototherapy for severe dermographism
(Figure 1). Eight months earlier, a similar course of
treatment resulted in complete clearance of her dermo-
graphism. It had,however, recurred rapidly over 2 months.
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referral for phototherapy. At the time of presentation to us,
she had a slightly raised alanine aminotransferase (ALT)
and alkaline phosphatase but investigation for possible
explanations of these findings, and an underlying cause of
generalised itch might be exacerbating her dermograph-
ism, was unrevealing. On her twelfth attendance at the
phototherapy unit, she reported that she was being
investigated for possible heart disease following an
admission to an Acute Medical Unit after she developed
chest pain after a fall on an icy pavement. A chest X-ray and
electrocardiogram had not shown any abnormalities and
an exercise tolerance test was awaited. We requested her
blood test reports which revealed a high creatine
phosphokinase (CK) of 6195U/L (reference range: 30-
120) and troponin T (Elecsys Modular Analytics E170
[Roche Diagnostics]; reagent kit Cat. No 12017644) of
0.14μ g/L (reference range 0-0.01).
She was reassessed. Her dermographism was improving
but she had developed confluent erythema and slight
hyperkeratosis between and over the dorsae of her fingers.
She had dilated nailfold capillaries on the little finger of
her right hand. Specific questioning elicited a history of
proximal arm discomfort when lifting heryoung child. She
had slight difficulty when asked to rise from a chair
without using her arms. The combination of these skin
changes, the muscle symptoms and her elevated muscle
enzymes suggested a diagnosis of dermatomyositis. We
admitted her for rest and to expedite investigations.
Histopathology of a muscle biopsy and electromyography
features supported the impression of inflammatory
myositis consistent with dermatomyositis. A transthoracic
echocardiogram did not show any abnormalities. No
malignancy was found in her history, or during examina-
tion and investigation. Oral systemic corticosteroids were
started.
At outpatient review, soon after discharge, her dermato-
myositis was responding well to treatment. We requested
troponin T as well as CK. Her CK had fallen to 3000 and
her troponin T to 0.10. These results were telephoned
through to her general practice (before being returned to
us in hospital) and, alarmed by the high troponin T, a
locum general practitioner referred her urgently to the
Acute Medical Unit (AMU) that night. One of us, who had
reviewed her earlier that day in outpatients, overheard a
telephone enquiry about her seeking her case notes from
the AMU to our ward. On assessment, there was nothing
new of concern and, after reassurance that her blood test
results were improving, she was allowed home.
After an initial response to oral corticosteroids alone, the
rate of improvement in her condition slowed. Therefore,
high-dose human intravenous immunoglobulin (IVIG)
therapy was added [4]. Shortly after the first IVIG infusion,
her symptoms and biochemical features started to
improve quickly (Figure 2). A few months after starting
regular IVIG, her CK reached near normal population
values and her skin and muscle symptoms and signs
resolved. Her dermographism completely resolved, and
has not recurred. Her condition continued to gradually
improve. The IVIG infusion frequency was reduced and
then infusions stopped. She was maintained on a low dose
of prednisolone during a pregnancy, 4 years after her
diagnosis. This had to be increased to 10 mg daily for a few
Figure 1. Dermographic urticaria resulting from pressure
through clothing.
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Figure 2. Change in creatine kinase (U/L) over time.
The vertical maroon lines indicate IVIG infusions.
The horizontal dashed line indicates the upper limit
of the reference interval for CK.
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disease, but has now been reduced again.
Discussion
Possibly, our patient’s symptomatic dermographism was
coincidental to her presentation with dermatomyositis.
Dermographism is common, affecting about 5% of people
[5]. Her dermographism was particularly severe, requiring
UVB phototherapy [6]. We are suspicious that her
symptomatic dermographism was related to her dermato-
myositis, possibly through the mechanism of generalised
itch leading to rubbing and scratching and so making
much more evident what could otherwise have been only
mild dermographism. Although not reported in the
published literature, we have an impression that dermo-
graphism is more frequent, perhaps affecting almost half
of patients, in dermatomyositis than would be expected
by chance. Early during the course of her illness, she was
worried, we think unnecessarily, by an emergency admis-
sion which was prompted solely by a blood test result
report (the troponin T). Elevated troponin T has been
reported as a feature of dermatomyositis, possibly due to
cardiac muscle involvement [7]. Also, more recent
published correspondence has re-emphasised that tropo-
nin T is not a specific test for ischaemic cardiac damage [8].
Our management of this patient’s dermatomyositis was
fairly standard, although influenced by the fact that she
wanted to have more children, so we relied on predniso-
lone and, initially, IVIG infusions rather than other
systemic therapies. If we had needed to use other therapy,
then azathioprine would have been an option, as a drug
that does not seem to be teratogenic [9].
Conclusion
This case report illustrates two things. First, we report
symptomatic dermographism as the presenting feature of
dermatomyositis. Second, this case should be a reminder
to doctors from all medical specialities that while the
relatively recent widespread availability of troponin T
assays has been an important advance, troponin T can be
raised for reasons other than acute cardiac ischaemia.
Abbreviations
ALT, alanine aminotransferase; AMU, acute medical unit;
CK, creatine phosphokinase; IVIG, high-dose human
intravenous immunoglobin; UVB, ultraviolet B.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RD initially saw, and followed up this patient throughout
the course of her illness. KR saw the patient during some
review visits and wrote the initial drafts of the manuscript.
Both authors read and approved the final manuscript.
References
1. Shirani Z, Kucenic MJ, Carroll CL, Fleischer AB Jr, Feldman SR,
Yosipovitch G, Jorizzo JL: Pruritus in adult dermatomyositis. Clin
Exp Dermatol 2004, 29:273-276.
2. Dundley JL, Carroll CL, Lang W, Snively B, Yosipovitch G,
Feldman SR, Jorizzo JL: Cutaneous symptoms of dermatomyo-
sitis significantly impact patients’ quality of life. J Am Acad
Dermatol 2006, 54:217-220.
3. Stone JH, Hellmann DB: Polymyositis and dermatomyositis.I n
Oxford Textbook of Medicine. 4th edition. Edited by Warrell DA,
Cox TM, Firth JM, Benz EJ Jr. Oxford: Oxford University Press;
2003:3.113-3.116.
4. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C,
Dinsmore ST, McCrosky S: A controlled trial of high-dose
intravenous immune globulin infusions as treatment for
dermatomyositis. N Engl J Med 1993, 329:1993-2000.
5. Kirby JD, Matthews CNA, James J, Duncan EHL, Warin RP: The
incidence and other aspects of factitious wealing (dermo-
graphism). Br J Dermatol 1971, 85:331.
6. Johnsson M, Falk ES, Volden G: UVB treatment of factitious
urticaria. Photodermatol 1987, 4:302-304.
7. Kobayashi S, Tanaka M, Tamura N, Hashimoto H, Hirose S: Serum
cardiac troponin T in polymyositis/dermatomyositis. Lancet
1992, 340:726.
8. Grove ML: Raised cardiac troponins: troponins seem to be
sensitive but not specific. BMJ 2004, 329:111.
9. Janssen NM, Genta MS: The effects of immunosuppressive and
anti-inflammatory medications on fertility, pregnancy, and
lactation. Arch Intern Med 2000, 160:610-619.
Page 3 of 3
(page number not for citation purposes)
Journal of Medical Case Reports 2009, 3:7319 http://jmedicalcasereports.com/jmedicalcasereports/article/view/7319
Do you have a case to share?
Submit your case report today
￿ Rapid peer review
￿ Fast publication
￿ PubMed indexing
￿ Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com